A case‐control study of human immunodeficiency virus infection and cancer in adults and children residing in Kampala, Uganda

Uganda offers a unique setting in which to study the effect of human immunodeficiency virus‐1 (HIV‐1) on cancer. HIV‐1 is prevalent there, and cancers which are known to be HIV‐associated, such as Kaposi's sarcoma and Burkitt's lymphoma, are endemic. Adults residing in Kampala, Uganda, presenting with cancer in city hospitals were interviewed and had an HIV test. Of the 302 adults recruited, 190 had cancers with a potentially infectious aetiology (cases). The remaining 112 adults with tumours not known to have an infectious aetiology formed the control group. In addition, 318 children who were also Kampala residents were recruited and tested for HIV: 128 with cancer (cases) and 190 with non‐malignant conditions (controls). HIV seroprevalence was 24% in adult controls and 6% in childhood controls. The odds of HIV seropositivity among cases with specific cancers (other than Kaposi's sarcoma in adults) were compared with that among controls, using odds ratios (ORs), estimated with unconditional logistic regression. All ORs were adjusted for age (<5, 5–14, 15–19, 30–44, 45+) and sex and, in adults, also for the number of lifetime sexual partners (1 or 2, 3–9, 10+). In adults, HIV infection was associated with a significantly (p < 0.05) increased risk of non‐Hodgkin's lymphoma [OR = 6.2, 95% confidence interval (CI) 1.9–19.9, based on 21 cases] and conjunctival squamous‐cell carcinoma (OR = 10.9, 95% CI 3.1–37.7, based on 22 cases) but not with cancer at other common sites, including liver and uterine cervix. In children, HIV infection was associated with a significantly increased risk of Kaposi's sarcoma (OR = 94.9, 95% CI 28.5–315.3, based on 36 cases) and Burkitt's lymphoma (OR = 7.5, 95% CI 2.8–20.1, based on 33 cases) but not with other cancers. The pattern of HIV‐associated cancers in Uganda is broadly similar to that described elsewhere, but the relative frequency of specific cancers, such as conjunctival carcinoma, in HIV‐infected people differs. © 2001 Wiley‐Liss, Inc.

[1]  A. Kamali,et al.  Seven-year trends in HIV-1 infection rates, and changes in sexual behaviour, among adults in rural Uganda , 2000, AIDS.

[2]  V. Beral,et al.  The spectrum of HIV‐1 related cancers in South Africa , 2000, International journal of cancer.

[3]  V. Beral,et al.  HIV AND CANCER IN ADULTS AND CHILDREN IN KAMPALA, UGANDA. , 1999 .

[4]  Valerie Beral,et al.  Human immunodeficiency virus infection and cancer , 1998 .

[5]  V. Beral,et al.  The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic. , 1998, British Journal of Cancer.

[6]  S. Franceschi,et al.  Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy. Cancer and AIDS Registry Linkage Study. , 1998, British Journal of Cancer.

[7]  R. Selik,et al.  Cancer death rates associated with human immunodeficiency virus infection in the United States. , 1998, Journal of the National Cancer Institute.

[8]  J. Goedert,et al.  Spectrum of AIDS-associated malignant disorders , 1998, The Lancet.

[9]  F. Dabis,et al.  Human papillomavirus and human immunodeficiency virus infections: relation with cervical dysplasia‐neoplasia in African women , 1998, International journal of cancer.

[10]  V. Beral,et al.  Overview of the epidemiology of immunodeficiency-associated cancers. , 1998, Journal of the National Cancer Institute. Monographs.

[11]  W. Blattner,et al.  Non‐Hodgkin's lymphoma among people with AIDS: Incidence, presentation and public health burden , 1997 .

[12]  V. Beral,et al.  Risk factors for Kaposi's sarcoma in HIV‐positive subjects in Uganda , 1997, AIDS.

[13]  V. Beral,et al.  Association between human immunodeficiency virus type 1 infection and cancer in the black population of Johannesburg and Soweto, South Africa. , 1997, British Journal of Cancer.

[14]  R. Newton,et al.  A review of the aetiology of squamous cell carcinoma of the conjunctiva. , 1996, British Journal of Cancer.

[15]  S. Lewallen,et al.  Carcinoma of the conjunctiva and HIV infection in Uganda and Malawi. , 1996, The British journal of ophthalmology.

[16]  V. Beral,et al.  Cancer in Rwanda , 1996, International journal of cancer.

[17]  J. Ziegler,et al.  Kaposi's sarcoma in childhood: An analysis of 100 cases from Uganda and relationship to HIV infection , 1996, International journal of cancer.

[18]  J. Ferlay,et al.  Cancer in the african population of harare, Zimbabwe, 1990–1992 , 1995, International journal of cancer.

[19]  C. Chintu,et al.  Childhood cancers in Zambia before and after the HIV epidemic. , 1995, Archives of disease in childhood.

[20]  J. Goedert,et al.  Conjunctival malignant disease with AIDS in USA , 1995, The Lancet.

[21]  V. Beral,et al.  Cancer and HIV infection in Rwanda , 1995, The Lancet.

[22]  E. Cesarman,et al.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. , 1995, The New England journal of medicine.

[23]  C. Ateenyi-Agaba.  Conjunctival squamous-cell carcinoma associated with HIV infection in Kampala, Uganda , 1995, The Lancet.

[24]  E. Cesarman,et al.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. , 1994, Science.

[25]  M. Diomande,et al.  HIV‐associated lymphoma in Africa: An autopsy study in Ĉote D'ivoire , 1994, International journal of cancer.

[26]  M. McGrath,et al.  Pathogenesis of AIDS lymphomas. , 1994, AIDS.

[27]  D. Parkin,et al.  Cancer in Kampala, Uganda, in 1989–91: Changes in incidence in the era of aids , 1993, International journal of cancer.

[28]  V. Beral,et al.  AIDS-associated non-Hodgkin lymphoma , 1991, The Lancet.

[29]  P. Perre,et al.  HIV and conjunctival malignancies , 1990, The Lancet.

[30]  R. Baker,et al.  The GLIM System-Release 3 , 1979 .